Chronic Kidney Disease in Cats: Slowing the Decline
Rapavie Veterinary Team · 2026년 7월 21일
Short answer: Chronic kidney disease affects a large share of cats over ten and cannot be reversed — lost nephrons do not come back. What can change is the rate of decline. Early detection through SDMA and creatinine testing, a therapeutic renal diet, blood pressure and phosphate control, and good hydration together add years of comfortable life. Rapamycin's role here is a research question, not an established treatment.
Why CKD is caught so late
The feline kidney has substantial reserve. A cat can lose a majority of functioning nephrons before anything visible changes, and the clinical signs owners notice — drinking more, urinating more, losing weight — appear only once that reserve is spent.
By then the disease is well established. This is the central problem with CKD: the window where intervention does most good is the window where the cat still looks perfectly healthy.
What is actually happening in the kidney
Nephrons are lost progressively and replaced with scar tissue — fibrosis. The surviving nephrons compensate by working harder, which stresses them in turn and accelerates their own loss. It is a self-reinforcing cycle, which is why CKD tends to progress rather than plateau.
Fibrosis is the mechanistic reason mTOR appears in the research literature at all: mTOR signalling participates in the fibrotic response. That is a plausible target, and it is being investigated — but plausible mechanism is not clinical evidence, and no rapamycin protocol has been shown to change the course of feline CKD.
Detection: what to ask for
SDMA rises earlier than creatinine and is now standard in senior feline blood panels. Creatinine remains the staging backbone. Urine specific gravity matters as much as the blood work — a cat whose kidneys are failing to concentrate urine is showing early disease even with normal creatinine. Blood pressure should be measured, because hypertension both results from and worsens kidney damage. Urine protein predicts progression.
The practical recommendation: annual bloodwork from around age seven, twice yearly from eleven, and always paired with urine testing.
What actually slows progression
Therapeutic renal diet. This is the single best-evidenced intervention in feline CKD. Restricted phosphate, moderated and high-quality protein, added omega-3s. Studies show longer survival on renal diets. The difficulty is palatability — a diet the cat refuses helps nobody, so transitions should be gradual.
Phosphate control. Rising phosphate drives further damage. Diet does most of the work; binders are added when it is not enough.
Blood pressure management. Hypertension damages kidneys, eyes and brain. It is treatable, and treating it protects all three.
Hydration. Cats have a weak thirst drive. Wet food meaningfully increases total water intake; fountains help some cats; subcutaneous fluids are used in advanced disease.
Treating proteinuria. Protein leaking into urine predicts faster decline and can be reduced with specific medication.
Notice that the list is unglamorous. It is also genuinely effective — cats diagnosed early and managed properly often live for years.
Where the research is going
Slowing fibrosis is the obvious next frontier, since fibrosis is what converts a functioning kidney into a scarred one. mTOR inhibition is among the mechanisms under investigation, and clinical work in cats is ongoing at veterinary schools.
For now, the honest position is: interesting mechanism, active research, no established protocol. Any longevity-focused plan for a cat with CKD is built on the fundamentals above, with the kidney status specifically reviewed by the veterinarian before any additional medication is considered.
The honest summary
CKD is not curable, but its pace is modifiable. The gap between "diagnosed early and managed well" and "diagnosed at crisis" is measured in years of good life. Screening is the lever that matters most, and it works only while the cat still seems fine.
읽는 것이 첫걸음입니다. 고양이의 현재 상태를 아는 것이 그다음입니다.
모든 Rapavie 프로그램은 제품이 아니라, 면허 수의사가 반려동물의 병력을 검토하는 것에서 시작합니다.
라파마이신은 처방 의약품입니다. 수의사 검토 없이는 조제되지 않습니다.
